Product Code: ETC312087 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Singapore Aminoglycosides Market is projected to witness mixed growth rate patterns during 2025 to 2029. The growth rate begins at 5.71% in 2025, climbs to a high of 5.80% in 2026, and moderates to 4.16% by 2029.
By 2027, the Aminoglycosides market in Singapore is anticipated to reach a growth rate of 5.69%, as part of an increasingly competitive Asia region, where China remains at the forefront, supported by India, Japan, Australia and South Korea, driving innovations and market adoption across sectors.
The Singapore aminoglycosides market is a critical segment of the pharmaceutical industry, as these antibiotics are used to treat severe bacterial infections. With the ongoing development of healthcare infrastructure and increasing healthcare expenditure in Singapore, the demand for aminoglycosides is expected to rise. However, market growth may face challenges such as antibiotic resistance and regulatory scrutiny. Pharmaceutical companies will need to focus on research and development to create novel antibiotics and maintain the effectiveness of existing aminoglycosides.
The aminoglycosides market in Singapore is primarily fueled by their use as antibiotics in the healthcare sector. Aminoglycosides are effective against a wide range of bacterial infections, making them essential for treating serious medical conditions. The increasing prevalence of bacterial infections and the emergence of drug-resistant strains are driving the demand for aminoglycosides. Additionally, ongoing research and development activities focused on improving the safety and efficacy of these antibiotics are contributing to market growth.
The Singapore Aminoglycosides market faces several challenges. First and foremost, the growing concern of antibiotic resistance is a significant hurdle. Aminoglycosides are vital antibiotics used to treat severe infections, but their overuse can lead to resistance. Regulatory agencies are imposing stricter guidelines, impacting the availability and usage of these drugs. Additionally, pricing pressures from generic alternatives and the need for constant research and development to combat resistance contribute to the market`s challenges.
The Singapore aminoglycosides market, primarily associated with the pharmaceutical and healthcare sectors, faced both challenges and opportunities during the COVID-19 pandemic. On one hand, disruptions in the global pharmaceutical supply chain affected the availability of aminoglycosides. On the other hand, the demand for antibiotics, including aminoglycosides, surged due to increased healthcare requirements during the pandemic. Hospitals and healthcare facilities required these antibiotics for treating bacterial infections, including those associated with COVID-19. As a result, the market experienced a temporary boost in demand, highlighting the critical role of aminoglycosides in healthcare.
In the Singapore Aminoglycosides market, prominent players include multinational pharmaceutical companies like Pfizer, Novartis, and Sanofi, as well as local players such as Zuellig Pharma and Pharmaniaga.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Aminoglycosides Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Aminoglycosides Market Revenues & Volume, 2021 & 2031F |
3.3 Singapore Aminoglycosides Market - Industry Life Cycle |
3.4 Singapore Aminoglycosides Market - Porter's Five Forces |
3.5 Singapore Aminoglycosides Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Singapore Aminoglycosides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Singapore Aminoglycosides Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Singapore Aminoglycosides Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Singapore |
4.2.2 Growing demand for aminoglycosides due to their effectiveness in treating various bacterial infections |
4.2.3 Technological advancements leading to the development of novel aminoglycoside drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of aminoglycoside drugs in Singapore |
4.3.2 Concerns regarding the potential side effects and toxicity associated with aminoglycosides |
4.3.3 Competition from alternative antibiotics and antimicrobial agents in the market |
5 Singapore Aminoglycosides Market Trends |
6 Singapore Aminoglycosides Market, By Types |
6.1 Singapore Aminoglycosides Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Singapore Aminoglycosides Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Singapore Aminoglycosides Market Revenues & Volume, By Neomycin, 2021-2031F |
6.1.4 Singapore Aminoglycosides Market Revenues & Volume, By Tobramycin, 2021-2031F |
6.1.5 Singapore Aminoglycosides Market Revenues & Volume, By Gentamicin, 2021-2031F |
6.1.6 Singapore Aminoglycosides Market Revenues & Volume, By Amikacin, 2021-2031F |
6.1.7 Singapore Aminoglycosides Market Revenues & Volume, By Paromomycin, 2021-2031F |
6.1.8 Singapore Aminoglycosides Market Revenues & Volume, By Streptomycin, 2021-2031F |
6.1.9 Singapore Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 Singapore Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.2 Singapore Aminoglycosides Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Singapore Aminoglycosides Market Revenues & Volume, By Injectables (Parenteral), 2021-2031F |
6.2.3 Singapore Aminoglycosides Market Revenues & Volume, By Feed, 2021-2031F |
6.2.4 Singapore Aminoglycosides Market Revenues & Volume, By Intra-mammary, 2021-2031F |
6.2.5 Singapore Aminoglycosides Market Revenues & Volume, By Topical, 2021-2031F |
6.2.6 Singapore Aminoglycosides Market Revenues & Volume, By Oral, 2021-2031F |
6.3 Singapore Aminoglycosides Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Singapore Aminoglycosides Market Revenues & Volume, By Veterinary, 2021-2031F |
6.3.3 Singapore Aminoglycosides Market Revenues & Volume, By Skin Infection, 2021-2031F |
6.3.4 Singapore Aminoglycosides Market Revenues & Volume, By Respiratory diseases, 2021-2031F |
6.3.5 Singapore Aminoglycosides Market Revenues & Volume, By UTI & Pelvic Diseases, 2021-2031F |
6.3.6 Singapore Aminoglycosides Market Revenues & Volume, By Other diseases, 2021-2031F |
7 Singapore Aminoglycosides Market Import-Export Trade Statistics |
7.1 Singapore Aminoglycosides Market Export to Major Countries |
7.2 Singapore Aminoglycosides Market Imports from Major Countries |
8 Singapore Aminoglycosides Market Key Performance Indicators |
8.1 Rate of adoption of newly developed aminoglycoside drugs in Singapore hospitals |
8.2 Number of clinical trials conducted on aminoglycosides in Singapore |
8.3 Percentage of aminoglycoside prescriptions out of total antibiotic prescriptions in Singapore |
8.4 Utilization rate of aminoglycosides in critical care settings |
8.5 Patient outcomes and mortality rates in Singapore related to aminoglycoside treatment |
9 Singapore Aminoglycosides Market - Opportunity Assessment |
9.1 Singapore Aminoglycosides Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Singapore Aminoglycosides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Singapore Aminoglycosides Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Singapore Aminoglycosides Market - Competitive Landscape |
10.1 Singapore Aminoglycosides Market Revenue Share, By Companies, 2024 |
10.2 Singapore Aminoglycosides Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |